APO-VORTIOXETINE 15 MG
VORTIOXETINE (VORTIOXETINE HYDROBROMIDE) : 15 MG · DIN 02552760 · APOTEX INC
Health Canada status: APPROVED
What is APO-VORTIOXETINE?
APO-VORTIOXETINE 15 MG contains VORTIOXETINE (VORTIOXETINE HYDROBROMIDE) : 15 MG. It is listed in the Health Canada Drug Product Database under DIN 02552760, held by APOTEX INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as approved, status dated 07-Mar-2025. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02552760 |
|---|---|
| Brand name | APO-VORTIOXETINE |
| Generic / active ingredient | VORTIOXETINE (VORTIOXETINE HYDROBROMIDE) : 15 MG |
| Manufacturer | APOTEX INC |
| Strength | 15 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | N06AX26 VORTIOXETINE |
| Biosimilar | No |
| Health Canada status | APPROVED |
| Status date | 07-Mar-2025 |
What can be used instead?
Other Canadian products sharing ATC code N06AX26 VORTIOXETINE. 6 of 8 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-VORTIOXETINE | 10 MG | TABLET | APOTEX INC | MARKETED | DIN 02552752 |
| APO-VORTIOXETINE | 20 MG | TABLET | APOTEX INC | MARKETED | DIN 02552779 |
| APO-VORTIOXETINE | 5 MG | TABLET | APOTEX INC | MARKETED | DIN 02552744 |
| TRINTELLIX | 10 MG | TABLET | LUNDBECK CANADA INC | MARKETED | DIN 02432927 |
| TRINTELLIX | 20 MG | TABLET | LUNDBECK CANADA INC | MARKETED | DIN 02432943 |
| TRINTELLIX | 5 MG | TABLET | LUNDBECK CANADA INC | MARKETED | DIN 02432919 |
| TRINTELLIX | 15 MG | TABLET | LUNDBECK CANADA INC | APPROVED | DIN 02432935 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.